Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

8.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
8.2K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

6.8K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The efficacy and predictive value of <sup>99m</sup>Tc-rituximab for sentinel lymph node biopsy in acral melanoma patients.

World journal of surgical oncology·2026
Same author

Self-assembled patient-derived tumor-like cell clusters for personalized drug testing in diverse sarcomas.

Cell reports. Medicine·2025
Same author

Intratumoral oncolytic virus OH2 injection in patients with locally advanced or metastatic sarcoma: a phase 1/2 trial.

Journal for immunotherapy of cancer·2025
Same author

Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial.

Clinical cancer research : an official journal of the American Association for Cancer Research·2024
Same author

AOC3 accelerates lung metastasis of osteosarcoma by recruiting tumor-associated neutrophils, neutrophil extracellular trap formation and tumor vascularization.

Heliyon·2024
Same author

Targeting MCM2 activates cancer-associated fibroblasts-like phenotype and affects chemo-resistance of liposarcoma cells against doxorubicin.

Anti-cancer drugs·2024

Related Experiment Video

Updated: Aug 12, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K

Specific gene module pair-based target identification and drug discovery.

Peng Li1, Chujie Bai2, Lingmin Zhan1

  • 1Shanxi key lab for modernization of TCVM, College of Basic Sciences, Shanxi Agricultural University, Jinzhong, Shanxi, China.

Frontiers in Pharmacology
|February 2, 2023
PubMed
Summary

This study introduces a new method for identifying drug targets by analyzing gene expression patterns, bypassing the need for reference drugs. This approach successfully discovered novel inhibitors for key PI3K pathway proteins.

Keywords:
drug discoverydrug target predictiondrug–target associationgene module pairtranscriptome

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

Related Experiment Videos

Last Updated: Aug 12, 2025

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
09:33

Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens

Published on: August 25, 2023

1.2K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.2K
High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
07:51

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

Published on: May 21, 2018

11.9K

Area of Science:

  • Pharmacology and Drug Discovery
  • Systems Biology
  • Computational Biology

Background:

  • Identifying drug targets is crucial for understanding drug mechanisms and developing new therapeutics.
  • The Connectivity Map (CMap) links genes, drugs, and diseases via gene-expression signatures but can be inefficient.
  • Existing CMap methods rely on reference drugs, limiting direct compound-target interaction inference.

Purpose of the Study:

  • To develop a more efficient method for identifying compound-target interactions.
  • To establish a direct link between chemical compounds and their biological targets.
  • To enable the discovery of novel drug candidates and their mechanisms of action.

Main Methods:

  • Developed a procedure to extract target-induced consensus gene modules from transcriptional profiles.
  • Defined a transcriptional gene module pair (GMP) as a direct target signature.
  • Constructed a target network based on GMPs and proposed a gene module pair-based target identification (GMPTI) approach.

Main Results:

  • Successfully identified target-induced consensus gene modules and GMPs for specific targets.
  • Built a target network revealing clusters of genes with similar biological mechanisms.
  • The GMPTI approach predicted novel compound-target interactions effectively.
  • Discovered novel inhibitors for PI3K pathway proteins PI3Kα/β/δ, including PU-H71, alvespimycin, reversine, astemizole, raloxifene HCl, and tamoxifen.

Conclusions:

  • The developed GMPTI approach offers a direct and efficient method for compound-target interaction prediction.
  • This method facilitates the discovery of novel therapeutic agents by identifying direct drug targets.
  • The findings advance drug discovery by providing a new tool for target identification and mechanism of action studies.